ESR要点:动脉血管入路与闭合装置——欧洲心血管与介入放射学会实践推荐
欧洲心血管与介入放射学会发布动脉血管入路与闭合装置实践推荐,强调股动脉入路强烈推荐超声引导,困难入路必须使用超声;股动脉止血使用血管闭合装置总体安全有效且有I级证据支持,但外周动脉介入中并发症获益不明确,建议对≥5 Fr股动脉入路个体化使用。
要点
- 股动脉入路强烈推荐实时超声引导,困难入路必须使用超声。
- 股动脉止血使用血管闭合装置总体安全有效,有I级证据支持。
- 外周动脉介入中血管闭合装置并发症获益未明确,建议个体化使用。
核心结论
- 股动脉入路强烈推荐超声引导,困难入路必须使用超声;股动脉止血使用血管闭合装置总体安全有效且有I级证据支持,但外周动脉介入中并发症获益未明确,建议对≥5 Fr股动脉入路个体化使用血管闭合装置。
研究设计与样本
- 欧洲心血管与介入放射学会实践推荐,基于文献综述与证据分级;支持超声引导的高级别证据主要来自仅研究桡动脉和股动脉入路的随机心脏试验。
诊断标准与关键数值
- 股动脉入路强烈推荐超声引导,困难入路必须使用超声;股动脉止血使用血管闭合装置有I级证据支持安全有效;对≥5 Fr股动脉入路建议个体化使用血管闭合装置。
临床应用与阅片要点
- 股动脉入路强烈推荐超声引导,困难入路必须使用超声;股动脉止血使用血管闭合装置总体安全有效且有I级证据支持;对≥5 Fr股动脉入路建议个体化使用血管闭合装置,以缩短止血和下床时间、提高患者舒适度,并在出血风险增加、凝血异常和大口径入路时减少出血并发症;正确培训和根据患者个体特征选择合适装置对优化结局至关重要。
局限性
- 支持外周操作中超声引导推荐的高级别证据有限,A级数据主要来自仅研究桡动脉和股动脉入路的随机心脏试验。
- 现有数据未能明确显示外周血管内动脉介入中血管闭合装置相比标准手动压迫在并发症方面的获益。
- 血管闭合装置使用后报告的血栓和感染并发症仍是一个问题。
- 文献中因装置、入路部位、鞘管尺寸、临床场景和操作种类繁多而存在异质性,给数据分析和未来研究设计带来困难。
- 支持对出血风险增加、凝血异常和大口径入路个体化使用血管闭合装置以减少出血并发症的高级别证据有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Vascular access is the initial, very important, step of endovascular procedures. Various access sites include the common femoral artery, brachial artery, radial artery, popliteal artery, and distal tibial vessels (pedal arteries). Successful arterial access requires advanced knowledge of anatomy, as well as proper training and experience. Today, vascular access should be obtained using real-time, ultrasound guidance to reduce access time, patient discomfort, and puncture-related complications including dissection, arteriovenous communication, and bleeding. Nevertheless, high-level evidence to support this recommendation in peripheral procedures is limited and level A data are mainly derived from randomized cardiac trials investigating only radial and femoral access. Vascular closure devices (VCDs) for femoral access can be broadly categorized as active closure devices, compression assist devices, and external/topical hemostasis devices. There is high-level evidence demonstrating that their use is related to less time for ambulation and increased patient satisfaction. However, available data failed to clearly demonstrate a benefit in complications compared to standard manual compression in peripheral endovascular arterial procedures, and thrombotic and infectious complications reported following VCD use remain an issue. Heterogeneity noted in the literature, caused by the vast variety of devices, access sites, sheath sizes, clinical scenarios, and procedures, poses difficulties in data analysis and future study design. As a result, an individualized VCD use is currently suggested for ≥ 5 Fr femoral artery access not only to reduce time to hemostasis and ambulation and to improve patient comfort, but also to reduce bleeding complications in cases of femoral access with increased bleeding risk, deranged coagulation, and large-bore access, though a high level of evidence to support this later recommendation is limited. KEY POINTS: US guidance is strongly recommended for femoral access and is mandatory to obtain more challenging access. The use of VCDs for femoral hemostasis is generally safe, effective, and currently supported by level I evidence. Proper training and correct VCD choice, based on the patient's individual characteristics, are imperative to optimize outcomes.
引用
- Spiliopoulos S, Prountzos S, Grigoriadis S, et al. ESR Essentials: arterial vascular access and closure devices-practice recommendations by the Cardiovascular and Interventional Radiological Society of Europe. Eur Radiol. 2024. PMID: 39225792. doi:10.1007/s00330-024-11053-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。